Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05166239
What this trial is testing

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Peking University 66
Testing effectiveness (Phase 2)UnknownNCT02290977
What this trial is testing

Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Samsung Medical Center 40
Not applicableUnknownNCT03591705
What this trial is testing

TACE-HAIC vs. HAIC for Potentially Resectable HCC

Who this might be right for
Potentially ResectionHepatocellular Carcinoma
Sun Yat-sen University 240
Not applicableStudy completedNCT03132337
What this trial is testing

Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study

Who this might be right for
Sinusoidal Obstruction Syndrome
Indiana University 80
Testing effectiveness (Phase 2)Study completedNCT00149396
What this trial is testing

Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerLiver Neoplasms
MediGene 32
Testing effectiveness (Phase 2)Study completedNCT03693807
What this trial is testing

The Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

Who this might be right for
Colorectal CancerCholangiocarcinoma
Memorial Sloan Kettering Cancer Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT07636798
What this trial is testing

Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
West China Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05400902
What this trial is testing

HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Binkui Li 17
Not applicableUnknownNCT05788835
What this trial is testing

DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

Who this might be right for
HCC
Xuhua Duan 220
Testing effectiveness (Phase 2)Looking for participantsNCT07337460
What this trial is testing

Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

Who this might be right for
Hepatocellular Carcinoma (HCC)
Northern Jiangsu People's Hospital 30
Not applicableStudy completedNCT06265883
What this trial is testing

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 205
Testing effectiveness (Phase 2)Looking for participantsNCT07560488
What this trial is testing

Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular CarcinomaConversion Therapy
Tianjin Medical University Cancer Institute and Hospital 43
Testing effectiveness (Phase 2)WithdrawnNCT04178642
What this trial is testing

The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-Lipiodol

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Montpellier
Large-scale testing (Phase 3)Looking for participantsNCT06857773
What this trial is testing

Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Therapy With Systemic Therapy

Who this might be right for
Colorectal NeoplasmsFloxuridineLiver Metastases+1 more
The Netherlands Cancer Institute 306
Testing effectiveness (Phase 2)Study completedNCT00200200
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

Who this might be right for
Hepatic MetastasesColon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 73
Testing effectiveness (Phase 2)WithdrawnNCT03780634
What this trial is testing

HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)Study completedNCT00557102
What this trial is testing

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute, France 24
Testing effectiveness (Phase 2)UnknownNCT06375642
What this trial is testing

A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07201519
What this trial is testing

Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

Who this might be right for
Colorectal Cancer MetastaticIntrahepatic Cholangiocarcinoma
Michael J Cavnar, MD 80
Testing effectiveness (Phase 2)UnknownNCT05135364
What this trial is testing

HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure

Who this might be right for
Unresectable Hepatocellular Carcinoma
Yue Han 48
Next Page